Literature DB >> 20544314

Promise and pitfalls of animal models of schizophrenia.

David Feifel1, Paul D Shilling.   

Abstract

Animal models are indispensible tools for advancing understanding of the cause of any given disease and developing new treatments. Developing animal models for schizophrenia presents formidable challenges owing to the distinctively human nature of the symptoms that define it and the thus-far-obscured underlying biological mechanisms. Nevertheless, progress has been and continues to be made in this important field of endeavor. This article discusses the challenges facing investigators who seek to develop and use animal models for translational research in schizophrenia and the responses that have emerged to those challenges, as well as the likely pathways that will lead to future progress.

Entities:  

Mesh:

Year:  2010        PMID: 20544314      PMCID: PMC2895894          DOI: 10.1007/s11920-010-0122-x

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  41 in total

Review 1.  Phenotype of schizophrenia: a review and formulation.

Authors:  C A Tamminga; H H Holcomb
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

Review 2.  Rodent models of depression: reexamining validity without anthropomorphic inference.

Authors:  Philip V Holmes
Journal:  Crit Rev Neurobiol       Date:  2003

3.  The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.

Authors:  Keith H Nuechterlein; Michael F Green; Robert S Kern; Lyle E Baade; Deanna M Barch; Jonathan D Cohen; Susan Essock; Wayne S Fenton; Frederick J Frese; James M Gold; Terry Goldberg; Robert K Heaton; Richard S E Keefe; Helena Kraemer; Raquelle Mesholam-Gately; Larry J Seidman; Ellen Stover; Daniel R Weinberger; Alexander S Young; Steven Zalcman; Stephen R Marder
Journal:  Am J Psychiatry       Date:  2008-01-02       Impact factor: 18.112

Review 4.  Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review.

Authors:  M A Geyer; K Krebs-Thomson; D L Braff; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

Review 5.  Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures.

Authors:  Bruce I Turetsky; Monica E Calkins; Gregory A Light; Ann Olincy; Allen D Radant; Neal R Swerdlow
Journal:  Schizophr Bull       Date:  2006-11-29       Impact factor: 9.306

Review 6.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

Review 7.  Pharmacologic features and effects of neuroleptics.

Authors:  M V Seeman
Journal:  Can Med Assoc J       Date:  1981-10-15       Impact factor: 8.262

Review 8.  Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.

Authors:  Jared W Young; Susan B Powell; Victoria Risbrough; Hugh M Marston; Mark A Geyer
Journal:  Pharmacol Ther       Date:  2009-03-06       Impact factor: 12.310

Review 9.  The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia.

Authors:  Kuei Y Tseng; R Andrew Chambers; Barbara K Lipska
Journal:  Behav Brain Res       Date:  2008-12-03       Impact factor: 3.332

10.  The effects of cross-fostering on inherent sensorimotor gating deficits exhibited by Brattleboro rats.

Authors:  David Feifel; Kristianne Priebe
Journal:  J Gen Psychol       Date:  2007-04
View more
  7 in total

Review 1.  Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse.

Authors:  Matcheri S Keshavan; Henry A Nasrallah; Rajiv Tandon
Journal:  Schizophr Res       Date:  2011-02-12       Impact factor: 4.939

2.  Assessing Reality Testing in Mice Through Dopamine-Dependent Associatively Evoked Processing of Absent Gustatory Stimuli.

Authors:  Benjamin R Fry; Nicollette Russell; Ryan Gifford; Cindee F Robles; Claire E Manning; Akira Sawa; Minae Niwa; Alexander W Johnson
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

3.  Oxytocin in schizophrenia: a review of evidence for its therapeutic effects.

Authors:  Kai Macdonald; David Feifel
Journal:  Acta Neuropsychiatr       Date:  2011-12-19       Impact factor: 3.403

4.  Impaired reality testing in an animal model of schizophrenia.

Authors:  Michael A McDannald; Joshua P Whitt; Gwendolyn G Calhoon; Patrick T Piantadosi; Rose-Marie Karlsson; Patricio O'Donnell; Geoffrey Schoenbaum
Journal:  Biol Psychiatry       Date:  2011-07-27       Impact factor: 13.382

5.  Hypofrontality and Posterior Hyperactivity in Early Schizophrenia: Imaging and Behavior in a Preclinical Model.

Authors:  Gen Kaneko; Basavaraju G Sanganahalli; Stephanie M Groman; Helen Wang; Daniel Coman; Jyotsna Rao; Peter Herman; Lihong Jiang; Katherine Rich; Robin A de Graaf; Jane R Taylor; Fahmeed Hyder
Journal:  Biol Psychiatry       Date:  2016-05-30       Impact factor: 13.382

Review 6.  An Overview of Animal Models Related to Schizophrenia.

Authors:  Ian R Winship; Serdar M Dursun; Glen B Baker; Priscila A Balista; Ludmyla Kandratavicius; Joao Paulo Maia-de-Oliveira; Jaime Hallak; John G Howland
Journal:  Can J Psychiatry       Date:  2018-05-09       Impact factor: 4.356

7.  Clinical and Structural Differences in Delusions Across Diagnoses: A Systematic Review.

Authors:  Kelly Rootes-Murdy; David R Goldsmith; Jessica A Turner
Journal:  Front Integr Neurosci       Date:  2022-01-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.